These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 32764784)

  • 1. Secretome analysis reveals upregulated granzyme B in human androgen-repressed prostate cancer cells with mesenchymal and invasive phenotype.
    Bou-Dargham MJ; Sang QA
    PLoS One; 2020; 15(8):e0237222. PubMed ID: 32764784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epithelial to mesenchymal transition (EMT) in human prostate cancer: lessons learned from ARCaP model.
    Zhau HE; Odero-Marah V; Lue HW; Nomura T; Wang R; Chu G; Liu ZR; Zhou BP; Huang WC; Chung LW
    Clin Exp Metastasis; 2008; 25(6):601-10. PubMed ID: 18535913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgen-repressed phenotype in human prostate cancer.
    Zhau HY; Chang SM; Chen BQ; Wang Y; Zhang H; Kao C; Sang QA; Pathak SJ; Chung LW
    Proc Natl Acad Sci U S A; 1996 Dec; 93(26):15152-7. PubMed ID: 8986779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LIV-1 promotes prostate cancer epithelial-to-mesenchymal transition and metastasis through HB-EGF shedding and EGFR-mediated ERK signaling.
    Lue HW; Yang X; Wang R; Qian W; Xu RZ; Lyles R; Osunkoya AO; Zhou BP; Vessella RL; Zayzafoon M; Liu ZR; Zhau HE; Chung LW
    PLoS One; 2011; 6(11):e27720. PubMed ID: 22110740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the Nuclear Cathepsin L CCAAT Displacement Protein/Cut Homeobox Transcription Factor-Epithelial Mesenchymal Transition Pathway in Prostate and Breast Cancer Cells with the Z-FY-CHO Inhibitor.
    Burton LJ; Dougan J; Jones J; Smith BN; Randle D; Henderson V; Odero-Marah VA
    Mol Cell Biol; 2017 Mar; 37(5):. PubMed ID: 27956696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of minichromosome maintenance complex component 3 during epithelial-to-mesenchymal transition in human prostate cancer.
    Stewart PA; Khamis ZI; Zhau HE; Duan P; Li Q; Chung LWK; Sang QA
    Oncotarget; 2017 Jun; 8(24):39209-39217. PubMed ID: 28424404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate cancer metastasis: role of the host microenvironment in promoting epithelial to mesenchymal transition and increased bone and adrenal gland metastasis.
    Xu J; Wang R; Xie ZH; Odero-Marah V; Pathak S; Multani A; Chung LW; Zhau HE
    Prostate; 2006 Nov; 66(15):1664-73. PubMed ID: 16902972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptor activator of NF-kappaB Ligand (RANKL) expression is associated with epithelial to mesenchymal transition in human prostate cancer cells.
    Odero-Marah VA; Wang R; Chu G; Zayzafoon M; Xu J; Shi C; Marshall FF; Zhau HE; Chung LW
    Cell Res; 2008 Aug; 18(8):858-70. PubMed ID: 18645583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epitelial-to-mesenchimal transition and invasion are upmodulated by tumor-expressed granzyme B and inhibited by docosahexaenoic acid in human colorectal cancer cells.
    D'Eliseo D; Di Rocco G; Loria R; Soddu S; Santoni A; Velotti F
    J Exp Clin Cancer Res; 2016 Feb; 35():24. PubMed ID: 26830472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies of hormonal regulation, phenotype plasticity, bone metastasis, and experimental therapeutics in androgen-repressed human prostate cancer (ARCaP) model.
    Lo UG; Chen YA; Khamis ZI; Kao WH; Hsieh JT; Sang QA
    Am J Clin Exp Urol; 2021; 9(4):277-286. PubMed ID: 34541026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The involvement of FBP1 in prostate cancer cell epithelial mesenchymal transition, invasion and metastasis by regulating the MAPK signaling pathway.
    Zhang YP; Liu KL; Yang Z; Lu BS; Qi JC; Han ZW; Yin YW; Zhang M; Chen DM; Wang XW; Li W; Xin H
    Cell Cycle; 2019 Oct; 18(19):2432-2446. PubMed ID: 31448674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silibinin inhibits prostate cancer invasion, motility and migration by suppressing vimentin and MMP-2 expression.
    Wu KJ; Zeng J; Zhu GD; Zhang LL; Zhang D; Li L; Fan JH; Wang XY; He DL
    Acta Pharmacol Sin; 2009 Aug; 30(8):1162-8. PubMed ID: 19578386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of pro-gelatinase B by endometase/matrilysin-2 promotes invasion of human prostate cancer cells.
    Zhao YG; Xiao AZ; Newcomer RG; Park HI; Kang T; Chung LW; Swanson MG; Zhau HE; Kurhanewicz J; Sang QX
    J Biol Chem; 2003 Apr; 278(17):15056-64. PubMed ID: 12586837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muscadine grape skin extract reverts snail-mediated epithelial mesenchymal transition via superoxide species in human prostate cancer cells.
    Burton LJ; Barnett P; Smith B; Arnold RS; Hudson T; Kundu K; Murthy N; Odero-Marah VA
    BMC Complement Altern Med; 2014 Mar; 14():97. PubMed ID: 24617993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgen receptor mediates the reduced tumor growth, enhanced androgen responsiveness, and selected target gene transactivation in a human prostate cancer cell line.
    Cinar B; Koeneman KS; Edlund M; Prins GS; Zhau HE; Chung LW
    Cancer Res; 2001 Oct; 61(19):7310-7. PubMed ID: 11585771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression of epithelial and mesenchymal proteins in a panel of prostate cancer cell lines.
    Murali AK; Norris JS
    J Urol; 2012 Aug; 188(2):632-8. PubMed ID: 22704442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like growth factor-I-dependent up-regulation of ZEB1 drives epithelial-to-mesenchymal transition in human prostate cancer cells.
    Graham TR; Zhau HE; Odero-Marah VA; Osunkoya AO; Kimbro KS; Tighiouart M; Liu T; Simons JW; O'Regan RM
    Cancer Res; 2008 Apr; 68(7):2479-88. PubMed ID: 18381457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen receptor as a regulator of ZEB2 expression and its implications in epithelial-to-mesenchymal transition in prostate cancer.
    Jacob S; Nayak S; Fernandes G; Barai RS; Menon S; Chaudhari UK; Kholkute SD; Sachdeva G
    Endocr Relat Cancer; 2014 Jun; 21(3):473-86. PubMed ID: 24812058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA VIM-AS1 promotes prostate cancer growth and invasion by regulating epithelial-mesenchymal transition.
    Zhang Y; Zhang J; Liang S; Lang G; Liu G; Liu P; Deng X
    J BUON; 2019; 24(5):2090-2098. PubMed ID: 31786880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. hnRNPM, a potential mediator of YY1 in promoting the epithelial-mesenchymal transition of prostate cancer cells.
    Yang T; An Z; Zhang C; Wang Z; Wang X; Liu Y; Du E; Liu R; Zhang Z; Xu Y
    Prostate; 2019 Aug; 79(11):1199-1210. PubMed ID: 31251827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.